Cosmo Pharmaceuticals N.V.

CMOPF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$44,296$50,275$185,825$198,560
Short-Term Investments$98,667$0$55,128$23,647
Receivables$18,941$28,454$38,612$24,451
Inventory$13,510$14,198$11,498$13,119
Other Curr. Assets$26,844$9,299$15,034$16,072
Total Curr. Assets$202,258$102,226$306,097$275,849
Property Plant & Equip (Net)$29,088$28,588$30,277$30,478
Goodwill$24,005$24,005$24,005$24,005
Intangibles$331,925$355,624$366,838$372,733
Long-Term Investments-$66,827$3,286-$46,855$25,430
Tax Assets$18,716$0$14,680$18,636
Other NC Assets$107,607$40,251$64,550$58,431
Total NC Assets$444,514$451,754$453,495$529,713
Other Assets$0$0$0$0
Total Assets$646,772$553,980$759,592$805,562
Liabilities
Payables$9,100$8,783$7,588$4,102
Short-Term Debt$817$897$171,827$889
Tax Payable$20,611$2,681$2,736$3,596
Deferred Revenue$0$9,303$0$5,561
Other Curr. Liab.$17,740$4,050$16,155$7,088
Total Curr. Liab.$48,268$25,714$194,946$21,236
LT Debt$1,384$942$1,771$169,028
Deferred Rev, NC$0$0$0$479
Deferred Tax Liab, NC$90,811$94,534$97,097$99,749
Other NC Liab.$1,218$3,755$1,990$2,871
Total NC Liab.$93,413$99,230$100,858$271,648
Other Liabilities$0$0$0$0
Cap. Leases$1,780$1,280$1,968$2,639
Total Liabilities$141,681$124,944$295,804$292,884
Equity
Pref Stock$0$0$11,492$18,450
Common Stock$4,562$4,562$4,562$4,562
Retained Earnings$323,064$296,521$254,748$293,311
AOCI$0-$21,181-$11,492-$18,450
Other Equity$170,704$142,258$197,617$207,403
Total Equity$498,330$422,160$456,927$505,276
Supplemental Information
Minority Interest$6,761$6,806$6,861$7,402
Total Liab. & Tot. Equity$646,772$553,980$759,592$805,562
Net Debt-$42,095-$48,436-$12,227-$28,643